Journal Title：Familial Cancer

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician.

The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.

近年來，臨床癌癥遺傳學變得越來越重要。一些事件，特別是 DNA 技術的發(fā)展，促進了這一發(fā)展。臨床癌癥遺傳學現(xiàn)已發(fā)展成為一門真正多學科的醫(yī)學學科，臨床和分子遺傳學家與臨床和醫(yī)學腫瘤學家以及心理社會工作者一起工作。

由于臨床癌癥遺傳學的多學科性質，大多數(shù)論文目前發(fā)表在各種流行病學、腫瘤學和遺傳學期刊上?！都易逍园┌Y》提供了一個將這些主題匯集在一起??的論壇，重點關注臨床醫(yī)生的興趣和需求。

該期刊主要集中于臨床癌癥遺傳學。該領域的大多數(shù)主要領域都包括在內，例如家族性癌癥的流行病學、分子分析和診斷、臨床表現(xiàn)、治療和預防、咨詢和家族性癌癥的衛(wèi)生經(jīng)濟學。

Familial Cancer創(chuàng)刊于2001年，由Springer Netherlands出版商出版，收稿方向涵蓋遺傳學 - 醫(yī)學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)1.8，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。